This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-270035-1e1wzdri | The surgical manifestations of the intestinal tract in Kawasaki disease Gallbladder hydrops associated with Kawasaki disease: a case report and literature review Intestinal involvement in Kawasaki disease Gastrointestinal presentation of Kawasaki disease: a red flag for severe disease? |
| cord-007277-86lynlxn | A broad question would be: Is the pathogenesis of Kawasaki disease the product of HCoV- NH infection by itself? |
| cord-007277-86lynlxn | Alternatively, might there be another microbial pathogen involved in the pathogenesis of Kawasaki disease, such that it is a 2-hit disease requiring both a virus and a toxin? |
| cord-259996-uhrhsrky | The role of infection in Kawasaki syndrome Kawasaki disease: what is the epidemiology telling us about the etiology? |
| cord-003713-n3o8lwu4 | On the morphological alterations corresponding to the clinical manifestations Diagnosis, treatment, and longterm management of kawasaki disease: a scientific statement for health professionals from the American Heart Association Diagnosis, treatment, and longterm management of Kawa saki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young Council on Cardiovascular Disease in the Young; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease Kawasaki disease: is it caused by an infectious agent? |
| cord-003713-n3o8lwu4 | The etiology of Kawasaki disease: superantigen or conventional antigen? |
| cord-293714-s6ezxi5r | understanding pulmonary and extrapulmonary syndromes, pathogenesis and epidemiology of human Mycoplasma pneumonia infections Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures Kawasaki disease with a concomitant primary Epstein- Barr virus infection Adenovirus type 2 isolated from a patient with fatal Kawasaki disease Kawasaki disease and parvovirus B19 infection in an adult HIV-1-infected patient Isolation of human herpesvirus-6 from an infant with Kawasaki disease Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection Kawasaki disease associated with measles virus infection in a monozygotic twin Association of rotavirus infection with Kawasaki syndrome Concomitant dengue hemorrhagic fever with Kawasaki disease Kawasaki disease associated with chickenpox: report of two sibling cases Kawasaki disease coincident with influenza A H1N1/09 infection Kawasaki syndrome and concurrent Coxsackie- virus B3 infection Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens Association between a novel human coronavirus and Kawasaki disease Detection of human bocavirus in children with Kawasaki disease Kawasaki disease and human bocavirus e potential association? |
| cord-323202-kcy8xoos | This allowed us to assess whether the true clusters as a whole represented a departure from the comparison groups: that is, does the temporal clustering overall produce a different distribution of traits, beyond individual clusters? |
| cord-280280-9jr7ekbu | Diagnosis, Treatment and Prevention Options in Children Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature Epidemiology and clinical features of coronavirus disease 2019 in children COVID-19 virus and children: What do we know? |
| cord-353229-k3zerr83 | The factors affecting the disease course in Kawasaki disease Endothelial cell infection and endotheliitis in COVID-19 Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population Could MEFV mutation carriage status have a protective role for COVID-19 pandemia? |
| cord-018638-4pyjhpbk | : a state- of- the- art review Variations in ORAI1 gene associated with Kawasaki disease Transforming growth factor- beta signaling pathway in patients with Kawasaki disease Is Kawasaki disease an infectious disorder? |
| cord-018638-4pyjhpbk | Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan Kawasaki disease in India: increasing awareness or increased incidence? |
| cord-018638-4pyjhpbk | What dose of aspirin should be used in the initial treatment of Kawasaki disease? |
| cord-301160-7ik3iszp | results of the 2007- 2008 nationwide survey Epidemiologic features of Kawasaki disease in Taiwan Kawasaki disease in India: increasing awareness or increased incidence? |
| cord-314662-nem6dw34 | An increased risk for candidemia? |
| cord-314662-nem6dw34 | Temporally Associated with COVID-19 Interim Case Definition in New York State COVID-19 in newborns and infants- low risk of severe disease: Silver lining or dark cloud? |
| cord-292719-n5lg43tr | A review of 13 cases: is pseudomonas infection responsible? |
| cord-277908-d26xzean | What are the maternal and neonatal outcomes in planned home birth compared with hospital birth? |
| cord-277908-d26xzean | What is the association of social/ digital media viewing in the first 18 months of life and autism spectrum disorder( ASD)? |
| cord-277908-d26xzean | What thematic issues emerge from adolescent online- health- information searching behavior studies? |
| cord-333145-a20dlaxn | Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? |
| cord-030192-ebsh62ll | 17 Children: What Are the Differences? |
| cord-030192-ebsh62ll | A case series Acute respiratory failure in COVID-19: is it'typical'ARDS? |
| cord-030192-ebsh62ll | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-286607-5i406twr | Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single- center cohort of Italian patients with Kawasaki syndrome Critical overview of the risk scoring systems to predict non- responsiveness to intravenous immunoglobulin in Kawasaki syndrome Kawasaki disease incidence in children and adolescents: an observational study in primary care Epidemiologic features of Kawasaki disease in Japan: results of the 2009- 10 nationwide survey Kawasaki disease: what is the epidemiology telling us about the aetiology? |
| cord-286607-5i406twr | Has the microbiota played a critical role in the evolution of the adaptive immune system? |
| cord-286607-5i406twr | Is Kawasaki disease an infectious disorder? |
| cord-286607-5i406twr | NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpes- virus 8, TT virus, GB virus C/ hepatitis G virus or Chlamydia pneumoniae Kawasaki disease with a concomitant primary Epstein- Barr virus infection Adenovirus type 2 isolated from a patient with fatal Kawasaki disease Isolation of human herpesvirus-6 from an infant with Kawasaki disease Kawasaki disease associated with measles virus infection in a monozygotic twin Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection Concomitant dengue hemorrhagic fever with Kawasaki disease Kawasaki disease coincident with influenza A H1N1/09 infection Kawasaki syndrome and concurrent Coxsackie- virus B3 infection Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection Human adenovirus infection in Kawasaki disease: a confounding bystander? |
| cord-286607-5i406twr | The broad- ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas Non- infectious makers of Kawasaki syndrome: tangible or elusive triggers? |
| cord-331249-jrzgqq8q | A new infantile acute febrile mucocutaneous lymph node syndrome( MLNS) prevailing in Japan Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lynph node syndrome the same? |
| cord-331249-jrzgqq8q | The etiology of Kawasaki disease: superantigen or conventional antigen? |
| cord-331249-jrzgqq8q | where are the answers? |
| cord-024189-t7mbsr25 | A population- based study Does this patient have temporal arteritis? |
| cord-024189-t7mbsr25 | A review Is there a place for large vessel disease in the diagnostic criteria for Behçet's disease? |
| cord-024189-t7mbsr25 | Proposal of an international consensus conference Epidemiology of systemic vasculitis: changing incidence or defi nition? |
| cord-024189-t7mbsr25 | Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity Large- vessel vasculitis Is duplex ultrasonography useful for the diagnosis of giant- cell arteritis? |
| cord-312486-rumqopg0 | Management of patients with Crohn's Disease and Ulcerative Colitis during the coronavirus disease-2019 pandemic: results of an international meeting Factors associated with COVID-19-related death using OpenSAFELY Epigenetic dysregulation of ACE2 and interferon- regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients On the alert for cytokine storm: immunopathology in COVID-19 COVID-19-induced acute respiratory failure- an exacerbation of organ- specific autoimmunity? |
| cord-312486-rumqopg0 | What has SARS- CoV-2 revealed? |
| cord-312486-rumqopg0 | an overview The Complement System in COVID-19: Friend and Foe? |
| cord-312486-rumqopg0 | medRxiv Serum IgA, IgM, and IgG responses in COVID-19 Anti- SARS- CoV IgG response in relation to disease severity of severe acute respiratory syndrome Anti- spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS- CoV infection Antibodydependent infection of human macrophages by severe acute respiratory syndrome coronavirus Molecular mechanism for antibodydependent enhancement of coronavirus entry Clinical efficiency of intravenous immunoglobulin therapy in critical patients with COVID-19: a multicenter retrospective cohort study The potential danger of suboptimal antibody responses in COVID-19 Frequency of infection in patients with Rheumatoid Arthritis compared with controls: a population study Risk of severe herpes simplex virus infection in SLE: analysis of epidemiology and risk factors analysis in Taiwan Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? |
| cord-017161-lcqrd4v0 | A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis Long term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re treatment Rituximab versus cyclophosphamide in ANCA- associated renal vasculitis Rituximab versus cyclophosphamide for ANCAassociated vasculitis Biologic therapy in primary systemic vasculitis of the young Clinical features in 17 paediatric patients with Wegener granulomatosis Clinical features and outcome of pediatric Wegener's granulomatosis Childhood microscopic polyangiitis associated with MPO- ANCA Churg- Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? |
| cord-017161-lcqrd4v0 | Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? |
| cord-017161-lcqrd4v0 | How long? |
| cord-017161-lcqrd4v0 | How much? |
| cord-017161-lcqrd4v0 | Induction of remission in active anti- neutrophil cytoplasmic antibody- associated vasculitis with mycophenolate mofetil in patients who can not be treated with cyclophosphamide ANCA vasculitis: time for a change in treatment paradigm? |
| cord-017161-lcqrd4v0 | The treatment of Wegener's granulomatosis with trimethoprim/ sulfamethoxazole: illusion or vision? |
| cord-017161-lcqrd4v0 | What's new in the aetiopathogenesis of vasculitis? |
| cord-017161-lcqrd4v0 | key players towards the de fi nition of vascular competence Biomechanical activation: an emerging paradigm in endothelial adhesion biology Procoagulant microparticles: disrupting the vascular homeostasis equation? |
| cord-294729-c9f0iokr | Could further elucidation of these pathways demonstrate more refined targeted therapies with improved outcomes for this syndrome or previously described canonical KD? |
| cord-294729-c9f0iokr | Does this age- related increase in ACE-2 expression play a role in the observation that KD- like disease in SARS- CoV-2 infection occurs more frequently in an older population compared with KD and what other potential signaling pathways may be involved? |
| cord-294729-c9f0iokr | IFN responses provide further insights in additional therapies that may influence Janus kinases- STAT pathways? |
| cord-294729-c9f0iokr | IL-2R be more relevant than IL-6 and provide further insight into JAK1, JAK3, or other tyrosine kinase/ map kinase signaling pathways? |
| cord-294729-c9f0iokr | What mechanistically could describe findings of MIS- C at presentation and yet delayed findings of KD with coronary artery dilatation after four echocardiograms that have not been previously reported in large case series? |
| cord-294729-c9f0iokr | When and how often should echocardiogram surveillance occur with children that meet MIS- C criteria at admission but may not have evidence of KD? |
| cord-294729-c9f0iokr | Why in this illustrative case do we see a clinical presentation of vasodilatory shock with increased nonspecific inflammatory biomarkers and an absence of a"cytokine storm"of IL-6, TNF- α, or related proinflammatory cytokines but with profound lymphopenia and reduction in IFN- γ demonstrating immune exhaustion? |
| cord-294729-c9f0iokr | With oversampling of diagnostic testing including serial echocardiograms, are we unearthing a phenomenon restricted only to SARS- CoV-2 virus or would other common childhood viruses with the same testing reveal similar findings? |
| cord-269170-9f460xbq | Active or recent parvovirus B19 infection in children with kawasaki disease Kawasaki disease and human bocavirus- potential association? |
| cord-269170-9f460xbq | Epstein- barr virus genome- positive tubulointerstitial nephritis associated with kawasaki disease- like coronary aneurysms Could a herpesvirus be the cause of kawasaki disease? |
| cord-269170-9f460xbq | The etiology of kawasaki disease: retrovirus? |
| cord-269170-9f460xbq | Toxic shock syndrome toxin- secreting Staphylococcus aureus in kawasaki syndrome Polyclonal expansion of TCRBV2-and TCRBV6-bearing T cells in patients with kawasaki disease Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection Kawasaki disease- specific molecules in the sera are linked to microbeassociated molecular patterns in the biofilms Mycoplasma pneumoniae: a possible trigger of kawasaki disease or a mere coincidental association? |
| cord-269170-9f460xbq | What factors perturb the gut microbiota and cause dysbiosis in young children? |
| cord-269170-9f460xbq | toxin-1 may protect infants younger than 6 months of age from developing kawasaki syndrome Kawasaki disease: what is the epidemiology telling us about the etiology? |
| cord-261058-yu2qw02l | Could a herpesvirus be the cause of Kawasaki disease? |
| cord-261058-yu2qw02l | Does Kawasaki disease represent an extreme phenotype of a more pervasive phenomenon? |
| cord-261058-yu2qw02l | Is Kawasaki disease a variant of Q fever? |
| cord-261058-yu2qw02l | The etiology of Kawasaki disease: retrovirus? |
| cord-261058-yu2qw02l | What is the epidemiology telling us about the etiology? |
| cord-261058-yu2qw02l | Why is it important to understand the etiology and pathogenesis of Kawasaki disease? |
| cord-261058-yu2qw02l | last the etiology is clear? |
| cord-027870-cuvfy4pj | -coincidence or connection? |
| cord-027870-cuvfy4pj | : what is the epidemiology telling us about the etiology? |
| cord-027870-cuvfy4pj | : what is the epidemiology telling us about the etiology? |
| cord-027870-cuvfy4pj | A review of electrocardiographic and myocardial abnormalities and of treatment options Endocardial fi broelastosis associated with maternal anti- Ro and anti- La antibodies in the absence of atrioventricular block Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti- Ro autoantibodies Is isolated congenital heart block associated to neonatal lupus requiring pacemaker a distinct cardiac syndrome? |
| cord-027870-cuvfy4pj | An apparently new dominant mutation Pityrosporum infection in an infant with lesions resembling erythema annulare centrifugum Neonatal skin lesions due to a spirochetal infection: a case of congenital Lyme borreliosis? |
| cord-027870-cuvfy4pj | Blanching subcutaneous nodules in neonatal neuroblastoma Blueberry muffi n baby: neonatal neuroblastoma with subcutaneous metastases Cutaneous metastases in neuroblastoma Congenital alveolar rhabdomyosarcoma presenting as a blueberry muffi n baby Transient blueberry muffi n appearance of a newborn with congenital monoblastic leukemia Acute myelomonocytic leukemia with skin localizations Analysis and review of the world literature with report of an additional case Blueberry muffi n baby': hematopoiese extramedullaire neonatale? |
| cord-027870-cuvfy4pj | Characteristics of mothers and children enrolled in a national registry U1RNP positive neonatal lupus erythematosus: association with anti- La antibodies? |
| cord-027870-cuvfy4pj | Erythropoietic protoporphyria: treatment with antioxidants and potential cure with gene therapy Erythropoietic protoporphyria treated with narrowband( TL-01) UVB phototherapy Liver failure in protoporphyria: long- term treatment with oral charcoal Liver transplantation for erythropoietic protoporphyria: report of a case with medium- term follow- up Liver transplantation for erythropoietic protoporphyria liver disease Long- term follow- up after liver transplantation for erythropoietic protoporphyria Roles and pitfalls of transplantation in human porphyria Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? |
| cord-027870-cuvfy4pj | Myocarditis and coronary dilatation in the 1st week of life: neonatal incomplete Kawasaki disease? |
| cord-027870-cuvfy4pj | Ou histiocytose congenitale involutive? |
| cord-027870-cuvfy4pj | Response to dapsone A new infantile acute febrile mucocutaneous lymph node syndrome( MLNS) prevailing in Japan Kawasaki syndrome Kawasaki disease Kawasaki disease: recent advances Kawasaki disease in infants less than one year of age Clinical spectrum of Kawasaki disease in infants younger than 6 months of age Classical Kawasaki disease in a neonate Lethal vasculitis of coronary arteries in a neonate and two infants: possible neonatal variant of the MLNS/ IPN complex? |
| cord-027870-cuvfy4pj | The perineal eruption of Kawasaki syndrome Psoriatic eruption in Kawasaki disease Development of psoriatic lesions during acute and convalescent phases of Kawasaki disease Guttate psoriasis following Kawasaki disease Annular pustules in Kawasaki disease: a further case indicating the association with psoriasis? |
| cord-027870-cuvfy4pj | can paediatricians safely discontinue follow- up of children with a history of the disease but without cardiac sequelae? |
| cord-027870-cuvfy4pj | kDa Ro, anti-60 kDa Ro, and anti- La antibody profi les in neonatal lupus Autoantibody response to the Ro/ La particle may predict outcome in neonatal lupus erythematosus Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome- congenital heart block Anti- SSA/ Ro antibodies and the heart: more than complete congenital heart block? |
| cord-027870-cuvfy4pj | minor following vaccination with paediatric vaccines Controversy: are systemic steroids indicated in the treatment of erythema multiforme? |
| cord-027870-cuvfy4pj | monoblastique congenitale involutive? |
| cord-027870-cuvfy4pj | variant of Henoch- Schonlein purpura or a distinct clinical entity? |